Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumiracoxib vs Rofecoxib Safety Study in Osteoarthritis
NCT00637949Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2000
- Primary completion
- Mar 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of lumiracoxib in osteoarthritis (OA), sponsored by Novartis. Started Dec 2000; status: completed.
02
Drugs
lumiracoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00637949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637949.